Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
72.00
-0.68 (-0.94%)
Nov 13, 2026, 4:00 PM EST - Market closed

Monopar Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-25.49-16.7-16.16-8.83-10.54-9.13
Net Income
-20.6-13.72-15.59-8.4-10.52-9.1
Earnings Per Share
-2.41-1.85-4.11-3.04-4.13-3.65
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
129.45140.460.217.2713.1220.3
Total Debt
0.360.25--0.01-
Net Cash (Debt)
129.09140.1560.217.2713.1120.3
Net Cash Growth
-10.09%132.77%728.67%-44.58%-35.42%21.31%
Net Cash Per Share
15.1118.9115.892.635.158.14

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.95-12.2-6.4-7.86-7.23-7.32
Free Cash Flow
-15.95-12.2-6.4-7.86-7.23-7.32
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.